Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-001815
Filing Date
2023-06-20
Accepted
2023-06-20 19:39:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3222
  Complete submission text file 0001950047-23-001815.txt   4617
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37766 | Film No.: 231027058
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130 CAMBRIDGE MA 02139
Business Address
Clark Eliana (Reporting) CIK: 0001914448 (see all company filings)

Type: 144